PCLAF and neoplasm: In in vitro models, PAFR-expressing tumor cells generate more PAF agonists in response to chemotherapeutic agents and radiation therapy via activating tumoral PAFR, which has been shown to induce a prosurvival response to such therapeutic agents [29,30,31].